An analysis of the functional mechanisms of endostatin - The anti-angiogenic activity of endostatin is mediated by its multiple binding ability

Connective Tissue

Volumn 36, Issue 3, 2004, Pages 171-178

  Yamaguchi, Noriko ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis inhibitor; Anti tumor activity; Endostatin

Indexed keywords

AMINO ACID; ANGIOGENESIS INHIBITOR; CATHEPSIN L; CAVEOLIN 1; CELL ADHESION MOLECULE; COLLAGEN TYPE 18; COLLAGENASE 3; ELASTASE; ENDOSTATIN; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; FIBRONECTIN; FIBULIN; GELATIN; GELATINASE; GLYPICAN; HEMOPEXIN; HEPARIN; INTEGRIN; LAMININ; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; OXYGEN; PERLECAN; PROTEIN; PROTEOHEPARAN SULFATE; SYNTHETIC PEPTIDE; TISSUE INHIBITOR OF METALLOPROTEINASE; TROPOMYOSIN; UNINDEXED DRUG; ZINC;

ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BINDING AFFINITY; CELL ADHESION; CELL MIGRATION; CELL PROLIFERATION; EXTRACELLULAR MATRIX; HUMAN; NONHUMAN; REVIEW;

EID: 9144255639     PISSN: 0916572X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (57)

1. Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 27-31
2. Koch, A.E. (1998) Review: Angiogenesis: Implications for rheumatoid arthritis. Arthritis Rheum. 41, 951-962
3. Ferrara, N. and Alitalo, K. (1999) Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5, 1359-1364
4. Powell, J. (1999) Update on hemangiomas and vascular malformations. Curr. Opin. Pediatr. 11, 457-463
5. Folkman, J. (1971) Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285, 1182-1186
6. O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H., and Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315-328
7. O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J.R., Olssen, B.R., and Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277-285
8. Wen, W., Moses, M.A., Wiederschain, D., Arbiser, J.L., and Folkman, J. (1999) The generation of endostatin is mediated by elastase. Cancer Res. 59, 6052-6056
9. Felbor, U., Dreier, L., Bryant, R.A.R., Ploegh, H.L., Olsen, B.R., and Mothes, W. (2000) Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19, 1187-1194
10. Ferreras, M., Felbor, U., Lenhard, T., Olsen, B.R., and Delaissé, J.-M. (2000) Generation and degradation of human endostatin proteins by various proteinases. FEBS Lett. 486, 247-251
11. Muragaki, Y., Timmons, S., Griffith, C.M., Oh, S.P., Fadal, B., Quertermous, T., and Olsen, B.R. (1995) Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones. Proc. Natl. Acad. Sci. 92, 8763-8767
12. Saarela, J.M., Rhen, M., Oikarinen, A., Autio-Harmainen, H., and Pihlajaniemi, T. (1998) The short and long forms of type XVIII collagen show clear tissue specificities in their expression and location in basement membrane zones in humans. Am. J. Pathol. 153, 611-626
13. Halfer, W., Dong, S., Schurer, B., and Cole, G.J. (1998) Collagen XVIII is a basement membrane heparan sulfate proteoglycan. J. Biol. Chem. 273, 25404-25412
14. Yamaguchi, N., Anand-Apte, B., Lee, M., Sasaki T., Fukai, N., Shapiro, R., Que, I., Lowik, C., Timpl, R., and Olsen, B.R. (1999) Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J. 16, 4414-4423
15. Dhanabal, M., Ramchandran, R., Waterman, M.J.F., Lu, H., Knebelmann, B., Segal, M., and Sukhatme, V.P. (1999) Endostatin induces endothelial cell apoptosis. J. Biol. Chem. 274, 11721-11726
16. Schuch, G., Heymach, J.V., Nomi, M., Machluf, M., Force, J., Atala, A., Eder, J.P., Jr., Folkman, J., and Soker, S. (2003) Endostatin inhibits the vascular endothelial growth factor-induced mobilization of endothelial progenitor cells. Cancer Res. 63, 8345-8350
17. MacDonald, N.J., Shivers, W.Y., Narum, D.L., Plum, S. M., Wingard, J.N., Fuhrman, S.R., Liang, H., Holland-Linn, J., Tom Chen, D.H., and Kim Lee Sim, B. (2001) Endostatin binds tropomyosin. J. Biol. Chem. 276, 25190-25196
18. Maliery, S.R., Morse, M.A., Wilson, R.F., Pei, P., Ness, G.M., Bradburn, J.E., Renner, R.J., Schuller, D.E., and Robertson, F.M. (2003) AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomyosin microfilaments and inhibits cytokine-mediated migration and invasion. J. Cell. Biochem. 89, 133-143
19. Wilson, R.F., Morse, M.A., Pei, P., Renner, R.J., Schuller, D.E., Robertson, F.M., and Mallery, S.R. (2003) Endostatin inhibits migration and invasion of head and neck squamous cell carcinoma cells. Anticancer Res. 23, 1289-1295
20. Yu, Y., Moulton, K.S., Khan, M.K., Vineberg, S., Boye, E., Davis, V.M., O'Donnell, P.E., Bischoff, J., and Milstone, D.S. (2004) E-selectin is required for the antiangiogenic activity of endostatin. Proc. Natl. Acad. Sci. USA 101, 8005-8010
21. Kawashima, H., Watanabe, N., Hirose, M., Sun, X., Atarashi, K., Kimura, T., Shikata, K., Matsuda, M., Ogawa, D., Heljasvaara, R., Rehn, M., Pihlajaniemi, T., and Miyasaka, M. (2003) Collagen XVIII, a basement membrane heparan sulfate proteoglycan, interacts with L-selectin and monocyte chemoattractant protein-1. J. Biol. Chem. 278, 13069-13076
22. Hohenester, E., Sasaki, T., Olsen, B.R., and Timpl, R. (1998) Crystal structure of the angiogenesis inhibitor endostatin at 1.5 Å resolution. EMBO J. 17, 1656-1664
23. Kim, Y.-M., Jang, J.-W., Lee, O.-H., Yeon, J., Choi, E.-U., Kim, K.-W., Lee, S.-T., and Kwon, Y.-G. (2000) Endostatin inhibits endothelial and tumor cellular invasion by blocking the activation and catalytic activity of matrix metalloproteinase 2. Cancer Res. 60, 5410-5413
24. Lee, S.-J., Jang, J.-W., Kim, Y.-M., Lee, H.I., Jeon, J.Y., Kwon, Y.-G., and Lee, S.-T. (2002) Endostatin binds to the catalytic domain of matrix metalloproteinase-2. FEBS Letters 519, 147-152
25. Nyberg, P., Heikkilä, P., Sorsa, T., Luostarinen, J., Heljasvaara, R., Stenman, U.-H., Pihlajaniemi, T., and Salo, T. (2003) Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J. Biol. Chem. 278, 22404-22411
26. Dkhissi, F., Lu, H., Soria, C., Opolon, P., Grischelli, F., Liu, H., Khattar, P., Mishal, Z., Perricaudet, M., and Li, H. (2003) Endostatin exhibits a direct antitumor effect in addition to its antiangiogenic activity in colon cancer cells. Human Gene Ther. 14, 997-1008
27. Morbidelli, L., Donnini, S., Chillemi, F., Giacheti, A., and Ziehe, M. (2003) Angiosuppressive and angiostimulatory effects exerted by synthetic partial sequences of endostatin. Clin. Cancer Res. 9, 5358-5369
28. Cattaneo, M.G., Pola, S., Francescato, P., Chillemi, F., and Vicentini, L.M. (2003) Human endostatin-derived synthetic peptides possess potent antiangiogenic properties in vitro and in vivo. Exp. Cell Res. 283, 230-236
29. Chillemi, F., Francescato, P., Ragg, E., Cattaneo, M.G., Pola, S., and Vicentini, L. (2003) Studies on the structure-activity relationship of endostatin: synthesis of human endostatin peptides exhibiting potent antiangiogenic activities. J. Med. Chem. 46, 4165-4172
30. Griffioen, A.W., van der Schaft, D.W. J., Barendsz-Janson, A.F., Cox, A., Struijker Boudier, H.A.J., Hillen, H.P.P., and Mayo, K.H. (2001) Anginex, a designed peptide that inhibits angiogenesis. Biochem. J. 354, 233-242
31. Calvo, A., Yokoyama, Y., Smith, L.E., Ali, I., Shih, S.-C., Feldman, A.L., Libutti, S.K., Sundaram, R., and Green, J.E. (2002) Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin. Int. J. Cancer 101, 224-234
32. Yokoyama, Y. and Ramakrishnan, S. (2004) Improved biological activity of a mutant endostatin containing a single amino-acid substitution. Br. J. Cancer 90, 1627-1635
33. Rhen, M., Veikkola, T., Kukk-Valdre, E., Nakamura, H., Ilmonen, M., Lombarde, C.R., Philajaniemi, T., Alitalo, K., and Vuori, K. (2001) Interaction of endostatin with integrins implicated in angiogenesis. Proc. Natl. Acad. Sci. USA 98, 1024-1029
34. 1 and caveolin-1, and activates Src via a tyrosyl phosphatase-dependent pathway in human endothelial cells. Cancer Res. 62, 5580-5589
35. 1 integrins. Proc. Natl. Acad. Sci. USA 100, 4766-4771
36. 1 integrin, a possible cause of prevention of chondrosarcoma growth. J. Biochem. (Tokyo) 131, 619-626
37. Wickström, S.A., Alitalo, K., and Keski-Oja, J. (2004) An endostatin-derived peptide interacts with integrins and regulates actin cytoskeleton and migration of endothelial cells. J. Biol. Chem. 279, 20178-20185
38. Ding, Y.-H., Javaherian, K., Lo, K.-M., Chopra, R., Boehm, T., Lanciottti, J., Harris, B.A., Li, Y., Shapiro, R., Hohenester, E., Timpl, R., Folkman, J., and Wiley, D.C. (1998) Zinc-dependent dimers observed in crystals of human endostatin. Proc. Natl. Acad. Sci. USA 95, 10443-10448
39. Boehm, T., O'Reilly, M.S., Keough, K., Shiloach, J., Shapiro, R., and Folkman, J. (1998) Zinc-binding of endostatin is essential for its antiangiogenic activity. Biochem. Biophys. Res. Commun. 252, 190-194
40. Sasaki, T., Larsson, H., Kreuger, J., Salmivirta, M., Claesson-Welsh, L., Lindahl, U., Hohenester, E., and Timpl, R. (1999) Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin. EMBO J. 18, 6240-6248
41. Sasaki, T., Hohenester, E., and Timpl, R. (2002) Structure and function of collagen-derived endostatin inhibitors of angiogenesis. IUBMB Life 53, 77-84
42. Sasaki, T., Fukai, N., Mann, K., Göhring, W., Olsen, B. R., and Timpl, R. (1998) Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17, 4249-4256
43. Sasaki, T., Larsson, H., Tisi, D., Claesson-Welsh, L., Hohenester, E., and Timpl, R. (2000) Endostatins derived from collagens XV and XVIII differ in structural and binding properties, tissue distribution and anti-angiogenic activity. J. Mol. Biol. 301, 1179-1190
44. Ricard-Blum, S., Féraud, O., Lortat-Jacob, H., Rencurosi, A., Fukai, N., Dkhissi, F., Vittet, D., Imberty, A., Olsen, B.R., and van der Rest, M. (2004) Characterization of endostatin binding to heparin and heparan sulfate by surface plasmon resonance and molecular modeling. J. Biol. Chem. 279, 2927-2936
45. Kreuger, J., Matsumoto, T., Vanwildemeersch, M., Sasaki, T., Timpl, R., Claesson-Welsh, L., Spillmann, D., and Lindahl, U. (2002) Role of heparan sulfate domain organization in endostatin inhibition of endothelial cell function. EMBO J. 21, 6303-6311
46. Blackball, F.H., Merry, C.L.R., Lyon, M., Jayson, G.G., Folkman, J., Javaherian, K., and Gallagher, J.T. (2003) Binding of endostatin to endothelial heparan sulfate shows a differential requirement for specific sulphates. Biochem. J. 375, 131-139
47. Dixelius, J., Larsson, H., Sasaki, T., Holmqvist, K., Lu, L., Engström, Å., Timpl, R., Welsh, M., and Claesson-Welsh, L. (2000) Endostatin-induced tyrosine kinase signaling through the Shb adaptor protein regulates endothelial cell apoptosis. Blood 95, 3403-3411
48. Miosge, N., Simniok, T., Sprysch, P., and Herken, R. (2003) The collagen type XVIII endostatin domain is co-localized with perlecan in basement membranes in vivo. J. Histochem. Cytochem. 51, 285-296
49. Mogiat, M., Sweeney, S.M., San Antonio, J.D., Fu, J., and Iozzo, R.V. (2003) Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem. 278, 4238-4249
50. Karumanchi, S.A., Jha, V., Ramchandran, R., Karihaloo, A., Tsiokas, L., Chen, B., Dhanabal, M., Hanai, J., Venkataraman, G., Shriver, Z., Keiser, N., Kallluri, R., Zeng, H., Mukhopadhyay, D., Chen, R.L., Lander, A.D., Hagihara, K., Yamaguchi, Y., Sasisekharan, R., Cantley, L., and Sukhatme, V.P. (2001) Cell surface glypicans are low-affinity endostatin receptors. Mol. Cell 7, 811-822
51. Karihaloo, A., Karumanchi, S.A., Barasch, J., Jha, V., Nickel, C.H., Yang, J., Grisaru, S., Bush, K.T., Nigam, S., Rosenblum, N.D., Sukhatme, V.P., and Cantley, L.G. (2001) Endostatin regulates branching morphogenesis of renal epithelial cells and ureteric bud. Proc. Natl. Acad. Sci. USA 98, 12509-12514
52. Yamaguchi, N. (2001) Structure and functional role of type XVIII collagen/endostatin. Seikagaku 73, 1239-1245
53. Yamaguchi, N. and Ninomiya, Y. (2002) Angiogenesis inhibitors derived from basement membrane collagens. Connective Tissue 34, 165-173
54. Marneros, A.G. and Olsen, B.R. (2001) The role of collagen-derived proteolytic fragments in angiogenesis. Matrix Biol. 20, 337-345
55. Eriksson, K., Magnusson, P., Dixelius, J., Claesson-Welsh, L., and Cross, M.J. (2003) Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Letters 536, 19-24
56. Hajitou, A., Grignet-Debrus, C., Devy, L., Berndt, S., Blacher, S., Deroanne, C.F., Bajou, K., Fong, T., Chiang, Y., Foidart, J.-M., and Noël, A. (2002) The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells. FASEB J. doi: 10.1096/fj02-0109fje
57. Ding, I., Sun, J.Z., Fenton, B., Liu, W.M., Kimsely, P., Okunieff, P., and Min, W. (2001) Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas. Cancer Res. 61, 526-531